Core Insights - Mobilize Financial Services experienced a 3.3% increase in new financings, reaching €22.3 billion in 2025, reflecting strong operational management and commercial dynamism within the Renault Group [2][8] - The company reported pre-tax income of €1,181 million, slightly up from €1,179 million in 2024, indicating stable financial performance [6][18] Sales Performance - New financing volumes increased by 3.3% compared to 2024, driven by higher registrations for Renault Group, Nissan, and Mitsubishi [8] - The number of financing contracts rose by 1.7% to 1,270,556 in 2025 [8] - The penetration rate for electrified vehicles reached 46.6%, significantly higher than other engine types, which indicates a growing market for electric mobility [6][9] Financial Performance - Net Banking Income (NBI) was €2,224 million, a 2.7% increase from 2024, attributed to higher outstandings and improved financial margins [15] - Operating costs amounted to €747 million, representing 1.26% of Average Performing Assets (APA), showing a slight improvement from the previous year [17] - Total cost of risk was 0.36% of APA, up from 0.31% in 2024, but remains in line with historical averages [18] Customer Engagement and Services - Mobilize Financial Services sold 3.6 million service and insurance contracts in 2025, a decrease of 2.3% from 2024, with a focus on higher value-added services [10] - The company launched new insurance products in key markets, enhancing customer loyalty and adapting to evolving mobility needs [11][19] - The Net Promoter Score (NPS) improved to +60, indicating a high level of customer recommendation [13] Strategic Developments - The company continues to strengthen its partnerships, including a renewed collaboration with Nissan and a new partnership with Geely in Brazil, which supports its growth strategy [5] - Mobilize Financial Services is expanding its savings collection activities, having launched operations in Poland, contributing to a competitive funding source [16][22]

Core Viewpoint - Pulsar Helium Inc. has successfully raised approximately £7.4 million (around US$10.0 million / CAD$13.7 million) through an accelerated bookbuild placing of 9,191,175 shares at an issue price of £0.80 per share, aimed at advancing its helium projects in the USA [5][7]. Group 1: Fundraising Details - The company raised gross proceeds of approximately £7.4 million (approximately US$10.0 million / CAD$13.7 million) through the issuance of 9,191,175 placing shares [5]. - The placing was managed by OAK Securities, which acted as the exclusive bookrunner and placement agent [6]. Group 2: Use of Proceeds - The net proceeds from the placing will be utilized to advance the Topaz helium project in Minnesota, progress the Falcon project in Michigan, and for general working capital [11]. - At the Topaz project, the company plans to conduct extended well testing, reservoir evaluation, and additional seismic surveys, as well as update the independent resource estimate and complete a pre-feasibility study for integrated helium and CO₂ production [11]. Group 3: Admission and Shareholder Information - Application has been made for the admission of the placing shares to trading on AIM, expected to occur on or around February 27, 2026 [8][9]. - Upon admission, the total number of common shares in issue will be 180,142,697, which shareholders can use to determine their interest in the company's issued share capital [9].

Core Insights - RCI Banque has released its Business Report as of December 31, 2025, which is accessible on the Mobilize Financial Services website [1] Group 1 - The report provides a comprehensive overview of RCI Banque's financial performance and strategic initiatives for the year ending December 31, 2025 [1]

Core Viewpoint - Ramsay Health Care Limited (RHC) has proposed to distribute its 52.79% shareholding in Ramsay Santé to its shareholders, marking a significant strategic shift for the Group [1][2]. Group Overview - Ramsay Santé is a major player in private hospital care in France and Europe, operating independently of RHC with its own management team and governance framework [3]. - The Group has a strong financial position, supported by a standalone balance sheet and financing structure [3]. Strategic Implications - The Proposal aims to enhance Ramsay Santé's ability to serve patients more closely, backed by a broader shareholding and the commitment of its employees and medical partners [4]. - Ramsay Santé plans to continue its strategic roadmap focused on innovation, operational excellence, and rigorous financial management [4]. Leadership Perspective - CEO Pascal Roché emphasized that the proposal represents a new chapter for Ramsay Santé, highlighting the Group's solid resources and commitment to providing high-quality care [5]. - RHC has decided to terminate its shareholders' agreement with Crédit Agricole Assurances, which holds a 39.82% stake in Ramsay Santé, effective October 1, 2026 [5]. Shareholder Commitment - Crédit Agricole Assurances reaffirmed its long-term commitment as a shareholder of Ramsay Santé and confidence in the Group's strategy, while indicating no intention to increase its shareholding [6]. Implementation Details - The Proposal will be executed through a scheme of arrangement under Australian law, requiring approval from RHC's Board of Directors, shareholders, and necessary regulatory authorizations [7]. - Ramsay Santé will assess the legal, financial, and operational implications of the transaction to ensure stability in its capital structure [7]. Timeline - The Proposal could be implemented in Q4 2026, subject to required approvals, with an indicative timetable including employee consultations [8][14]. - Key milestones include the publication of a demerger booklet in October 2026, a shareholders meeting in November 2026, and completion of the transaction in December 2026 [14]. Company Profile - Ramsay Santé is the European leader in private hospitalization and primary care, employing 40,000 staff and 10,000 practitioners, serving 13 million patients annually across 492 facilities in five countries [10]. - The Group covers a wide range of care pathways, emphasizing innovation and equitable access to quality healthcare [11].

KH Group PlcStock Exchange Release28 January 2026 at 10:15 am EET Proposals of the Shareholders’ Nomination Board of KH Group Plc to the Annual General Meeting The Shareholders’ Nomination... Read More ...

Leadership Transition - Tuomas Myllynen has been appointed as the new CEO of KH-Koneet, effective from August 1, 2026, following the decision of long-standing CEO Teppo Sakari to step down and transition to a strategic advisor role [1][2] Executive Background - Myllynen has a significant background in executive roles, most recently serving as Managing Director of Cramo Finland, and holds an MSc from Tampere University of Technology [2] Company Vision - Myllynen expressed a clear vision for KH-Koneet, aiming to maintain its status as the most reliable partner for customers and to foster a collaborative workplace culture that values every employee's contribution [3] Company Overview - KH-Koneet is recognized as a leading provider of construction and earth-moving machinery in the Nordic countries, offering a wide range of machinery, equipment, and services for earthworks, property maintenance, and material handling [4] Corporate Structure - KH Group Plc, the parent company of KH-Koneet, operates in two business areas: construction and earth-moving machinery through KH-Koneet, and rescue vehicle manufacturing through Nordic Rescue Group. The company is listed on Nasdaq Helsinki [5]

Full-Year Results - The MT Højgaard Holding Group achieved stable operations and production in 2025, aligning with full-year expectations [1] Order Intake and Order Portfolio - In 2025, order intake increased due to improvements in both business units and across the Group's strategic focus areas, covering a range from small tasks to large, complex projects [2] - The total order book rose by 24% to a record DKK 24.2 billion, consisting of final unconditional orders worth DKK 11.9 billion, awarded but not yet contracted orders of DKK 8.5 billion, future projects valued at DKK 3.3 billion, and joint ventures worth DKK 0.5 billion [7] Financial Performance - Revenue decreased by 4% to DKK 10.2 billion, below expectations of DKK 10-10.5 billion, primarily due to the completion of major projects and low revenue from new multi-year projects [7] - Operating profit (EBIT) fell by 12% to DKK 429 million, with stable earnings from ongoing projects, influenced by one-time profits from land sales in 2024 [7] - Profit after tax from continuing operations was DKK 313 million, down from DKK 357 million in 2024, while net profit increased by 42% to DKK 268 million due to reduced losses in discontinued operations [7] - Cash flows from operating activities improved significantly to an inflow of DKK 181 million, compared to DKK 25 million in 2024 [7] Outlook for 2026 - The Group anticipates revenue and operating profit in 2026 to be on par with 2025 results, as several large phased projects will only contribute significantly from 2027-28 [3] - The Board of Directors proposed a dividend of DKK 10 per share, representing 29% of the annual profit, reflecting strong performance and improved solvency [7] Strategic Focus - The company concluded its "Building on" strategy with solid organic growth and portfolio adjustments, aiming to continue building from 2026 to 2028 while capitalizing on market opportunities [4]

Core Insights - IMCD N.V. has signed an agreement to acquire 100% of Willows Ingredients Group Limited, enhancing its capabilities in specialized health, sports, and animal nutrition sectors [1][3] - Willows Ingredients reported revenues of approximately EUR 26 million in 2024 and has a team of 26 employees with strong customer relationships [2][4] - The acquisition is expected to close in the first quarter of 2026, subject to customary closing conditions [4] Company Overview - IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients, headquartered in Rotterdam, Netherlands [5] - In 2025, IMCD reported revenues of EUR 4,779 million and has over 5,200 employees [6] - IMCD's shares are traded on Euronext Amsterdam and are included in the Dutch ESG AEX index, reflecting strong ESG practices [6] Strategic Implications - The acquisition will expand IMCD's presence in high-growth food and nutrition segments, broadening its portfolio and market access in Ireland and the UK [3][4] - The integration of Willows Ingredients' supplier partnerships is expected to create greater opportunities for customers and principals [4]

Core Insights - The company anticipates that Q4 2025 will mark a turning point, ending the quarter-on-quarter decline in results and positioning for renewed momentum into 2026 [3] Financial Performance - For Q4 2025, net sales were MSEK 710, down from MSEK 796 in Q4 2024, reflecting a currency-adjusted growth of -1% with -5% being organic [5][6] - EBITA for Q4 2025 decreased by 37% to MSEK 86, resulting in an EBITA margin of 12.1%, down from 17.0% in Q4 2024 [5][6] - Profit after tax for Q4 2025 was MSEK 55, a decrease of 34% compared to MSEK 84 in Q4 2024 [6] - Earnings per share for Q4 2025 were SEK 2.84, down 34% from SEK 4.30 in Q4 2024 [6] Annual Overview - For the full year 2025, net sales totaled MSEK 2,703, a decline from MSEK 2,802 in 2024, with a currency-adjusted growth of 3% and -1% organic growth [5][6] - EBITA for 2025 decreased by 25% to MSEK 274, with an EBITA margin of 10.2%, down from 13.0% in 2024 [5][6] - Profit after tax for 2025 was MSEK 133, down from MSEK 387 in 2024, with a 31% decrease when excluding reversed provisions of earn-out [6] - Earnings per share for 2025 were SEK 6.89, a decrease of 31% from SEK 19.93 in 2024, excluding reversed provisions [6] Dividend Proposal - The Board proposes a dividend of SEK 4.40 per share, to be paid in two installments of SEK 2.20 each [4] Tax Legislation Impact - Changes in U.S. tax legislation during 2025 positively impacted BTS's North American operations, resulting in a decrease of approximately MSEK 14 in reported income tax for the year [6][7]

Core Insights - EDF reported strong operational and financial results for 2025, driven by high nuclear power output and effective management of operational performance [2][4][6] - The company achieved a consolidated sales figure of €113.3 billion and an EBITDA of €29.3 billion, despite a decline from the previous year due to falling market prices [2][30] - EDF's net financial debt decreased to €51.5 billion, reflecting positive cash flow and effective debt management strategies [2][9][47] Financial Performance - Electricity output reached 515 TWh, with nuclear power contributing 373 TWh, marking the highest output in six years [2][16] - EBITDA decreased by 19.2% from €36.5 billion in 2024 to €29.3 billion in 2025, primarily due to lower sales prices and reduced hydropower output [6][18] - Net income attributable to the Group was €8.4 billion, down from €11.4 billion in 2024, largely due to lower EBITDA and non-recurring items [8][30] Operational Highlights - Nuclear output in France increased by 11.3 TWh to 373 TWh, while hydropower output decreased by 9.1 TWh to 46.4 TWh [16][19] - The company successfully reached 100% power at Flamanville 3 and provided a cost estimate of €72.8 billion for the EPR2 program [4][16] - EDF signed 47 TWh of medium- and long-term contracts by the end of 2025, enhancing stability for electricity-intensive customers [12] Market Position and Strategy - EDF's commitment to low-carbon electricity is reflected in its 95% carbon-free electricity output and a carbon intensity of 26.5 gCO2/kWh, which is 10.5% lower than in 2024 [16][42] - The company is focused on enhancing its operational performance through investments in nuclear and renewable energy projects, including Hinkley Point C and Sizewell C [4][16] - EDF aims to maintain a strong financial position with targets for net financial debt to EBITDA ratio of ≤ 2.5x and adjusted economic debt to adjusted EBITDA ratio of ≤ 4x by 2027 [5][6]